National Institutes of Health, 55930-55931 [2011-23095]
Download as PDF
mstockstill on DSK4VPTVN1PROD with NOTICES
55930
Federal Register / Vol. 76, No. 175 / Friday, September 9, 2011 / Notices
Date: October 6–7, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance, Washington, DC Hotel,
999 Ninth Street, NW., Washington, DC
20001–4427.
Contact Person: Olga A Tjurmina, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4030B,
MSC 7814, Bethesda, MD 20892, (301) 451–
1375, ot3d@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Macromolecular Structure and Function C.
Date: October 6, 2011.
Time: 10 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Arnold Revzin, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4146,
MSC 7824, Bethesda, MD 20892, (301) 435–
1153, revzina@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Drug Discovery and Molecular
Pharmacology Study Section.
Date: October 10–11, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Jeffrey Smiley, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194,
MSC 7804, Bethesda, MD 20892, 301–594–
7945, smileyja@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Biobehavioral Regulation, Learning and
Ethology.
Date: October 14, 2011.
Time: 9 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco Alexandria, 480 King
Street, Alexandria, VA 22314.
Contact Person: Biao Tian, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3166, MSC 7848, Bethesda, MD
20892, 301–402–4411, tianbi@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Center For Scientific Review Notice of
Closed Meetings
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee to the Director,
National Institutes of Health.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: September 2, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Dated: September 2, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–23091 Filed 9–8–11; 8:45 am]
[FR Doc. 2011–23147 Filed 9–8–11; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
VerDate Mar<15>2010
16:58 Sep 08, 2011
Jkt 223001
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: September 21, 2011.
Time: 9 a.m. to 11 a.m.
Agenda: ACD–NCATS Working Group will
present its recommendations to the full ACD
for discussion.
Place: National Institutes of Health,
Building 1, 1 Center Drive, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 103, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
This meeting is being published less than
15 days prior to the meeting due to
scheduling constraints.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group Radiation Therapeutics and Biology
Study Section.
Date: September 26–27, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Washington, 1515
Rhode Island Ave., NW., Washington, DC
20005.
Contact Person: Bo Hong, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict’s: Topics in Bioengineering,
Computation, and Biological Modeling 1.
Date: September 29–30, 2011.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Joseph Thomas Peterson,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9694, petersonjt@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group Child Psychopathology and
Developmental Disabilities Study Section.
Date: October 3–4, 2011.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Jane A DoussardRoosevelt, PhD, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
E:\FR\FM\09SEN1.SGM
09SEN1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 175 / Friday, September 9, 2011 / Notices
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group
Virology—B Study Section.
Date: October 4–5, 2011.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910.
Contact Person: John C Pugh, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1206,
MSC 7808, Bethesda, MD 20892, (301) 435–
2398, pughjohn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR–11–
045: Outcome Measures for Use in Treatment
Trials for Individuals with Intellectual and
Developmental Disabilities (R01).
Date: October 4, 2011.
Time: 1 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Jane A DoussardRoosevelt, PhD, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group Cancer Immunopathology and
Immunotherapy Study Section.
Date: October 13, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Denise R Shaw, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawdeni@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group
Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: October 13–14, 2011.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Admiral Fell Inn, 888 South
Broadway, Baltimore, MD 21231.
Contact Person: Guangyong Ji, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3188,
MSC 7808, Bethesda, MD 20892, 301–435–
1146, jig@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Mar<15>2010
16:58 Sep 08, 2011
Jkt 223001
Dated: September 1, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
55931
(Presidentially Declared Disasters); 97.039,
Hazard Mitigation Grant.
[FR Doc. 2011–23095 Filed 9–8–11; 8:45 am]
W. Craig Fugate,
Administrator, Federal Emergency
Management Agency.
BILLING CODE 4140–01–P
[FR Doc. 2011–23026 Filed 9–8–11; 8:45 am]
BILLING CODE 9111–23–P
DEPARTMENT OF HOMELAND
SECURITY
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–3329–
EM; Docket ID FEMA–2011–0001]
[Internal Agency Docket No. FEMA–3328–
EM; Docket ID FEMA–2011–0001]
Virginia; Amendment No. 1 to Notice of
an Emergency Declaration
New York; Amendment No. 1 to Notice
of an Emergency Declaration
Federal Emergency
Management Agency, DHS.
AGENCY:
ACTION:
Federal Emergency
Management Agency, DHS.
AGENCY:
Notice.
ACTION:
This notice amends the notice
of an emergency declaration for the
Commonwealth of Virginia (FEMA–
3329–EM), dated August 26, 2011, and
related determinations.
SUMMARY:
DATES:
Effective Date: August 29, 2011.
FOR FURTHER INFORMATION CONTACT:
Peggy Miller, Office of Response and
Recovery, Federal Emergency
Management Agency, 500 C Street, SW.,
Washington, DC 20472, (202) 646–3886.
The notice
of an emergency declaration for the
Commonwealth of Virginia is hereby
amended to include the following areas
among those areas determined to have
been adversely affected by the event
declared an emergency by the President
in his declaration of August 26, 2011.
SUPPLEMENTARY INFORMATION:
The counties of Essex, Gloucester, Henrico,
King George, King and Queen, Louisa, Surry,
Sussex, and York and the Independent City
of Richmond for emergency protective
measures (Category B), including direct
federal assistance, under the Public
Assistance program.
The following Catalog of Federal Domestic
Assistance Numbers (CFDA) are to be used
for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora
Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034,
Disaster Unemployment Assistance (DUA);
97.046, Fire Management Assistance Grant;
97.048, Disaster Housing Assistance to
Individuals and Households in Presidentially
Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance—
Disaster Housing Operations for Individuals
and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals
and Households—Other Needs; 97.036,
Disaster Grants—Public Assistance
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Notice.
This notice amends the notice
of an emergency declaration for the
State of New York (FEMA–3328–EM),
dated August 26, 2011, and related
determinations.
SUMMARY:
DATES:
Effective Date: August 28, 2011.
FOR FURTHER INFORMATION CONTACT:
Peggy Miller, Office of Response and
Recovery, Federal Emergency
Management Agency, 500 C Street, SW.,
Washington, DC 20472, (202) 646–3886.
The notice
of an emergency declaration for the
State of New York is hereby amended to
include the following areas among those
areas determined to have been adversely
affected by the event declared an
emergency by the President in his
declaration of August 26, 2011.
SUPPLEMENTARY INFORMATION:
Columbia, Delaware, Greene, Orange,
Putnam, Rockland, Schoharie, Sullivan,
Ulster, and Westchester Counties for
emergency protective measures (Category B),
including direct federal assistance, under the
Public Assistance program.
The following Catalog of Federal Domestic
Assistance Numbers (CFDA) are to be used
for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora
Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034,
Disaster Unemployment Assistance (DUA);
97.046, Fire Management Assistance Grant;
97.048, Disaster Housing Assistance to
Individuals and Households in Presidentially
Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance—
Disaster Housing Operations for Individuals
and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals
and Households—Other Needs; 97.036,
Disaster Grants—Public Assistance
E:\FR\FM\09SEN1.SGM
09SEN1
Agencies
[Federal Register Volume 76, Number 175 (Friday, September 9, 2011)]
[Notices]
[Pages 55930-55931]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-23095]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center For Scientific Review Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group Radiation Therapeutics and Biology Study Section.
Date: September 26-27, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Washington, 1515 Rhode Island Ave., NW.,
Washington, DC 20005.
Contact Person: Bo Hong, PhD, Scientific Review Officer, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301-996-6208,
hongb@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Member Conflict's: Topics in Bioengineering, Computation, and
Biological Modeling 1.
Date: September 29-30, 2011.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Joseph Thomas Peterson, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD
20892, 301-408-9694, petersonjt@csr.nih.gov.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group Child Psychopathology and Developmental
Disabilities Study Section.
Date: October 3-4, 2011.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Jane A Doussard-Roosevelt, PhD, Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD
20892, (301) 435-4445, doussarj@csr.nih.gov.
[[Page 55931]]
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group Virology--B Study Section.
Date: October 4-5, 2011.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Silver Spring, 8727 Colesville Road, Silver
Spring, MD 20910.
Contact Person: John C Pugh, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, pughjohn@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel PAR-11-045: Outcome Measures for Use in Treatment Trials for
Individuals with Intellectual and Developmental Disabilities (R01).
Date: October 4, 2011.
Time: 1 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Jane A Doussard-Roosevelt, PhD, Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD
20892, (301) 435-4445, doussarj@csr.nih.gov.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group Cancer Immunopathology and Immunotherapy Study Section.
Date: October 13, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Denise R Shaw, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6158, MSC 7804, Bethesda, MD 20892, 301-435-
0198, shawdeni@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: October 13-14, 2011.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Admiral Fell Inn, 888 South Broadway, Baltimore, MD
21231.
Contact Person: Guangyong Ji, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3188, MSC 7808, Bethesda, MD 20892, 301-435-
1146, jig@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 1, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-23095 Filed 9-8-11; 8:45 am]
BILLING CODE 4140-01-P